PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

AI in Drug Discovery
Auto Draft
Auto Draft
Elrig
Auto Draft
CPHI
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper

The Potential of IMS–MS for Clinical Applications of Untargeted Metabolomics

Metabolomics has expanded hugely in the last 10 years, as a result of the growing realisation of its value in driving advances in food and nutrition, agriculture, and especially healthcare. But with this has come the need to improve the ability of untargeted analytical methods to tackle the highly complex mixtures common in metabolomics. Prof. Zheng-Zhu Principal and Lucy Woods at Bruker Daltonics examine this challenge and look at the potential offered by the emerging technique of ion mobility spectrometry with mass spectrometry (IMS–MS).

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu